Comprehensive Genomic Profiling in Community Oncology
Recommendations to address limitations in more widespread use of reflex testing in community oncology.
Future Outlook: Coverage for Comprehensive Genomic Profiling in Oncology
How payers will support the use of comprehensive genomic profiling in oncology moving forward.
Future Outlook: Comprehensive Genomic Profiling in Oncology
Expectations regarding the future utilization of comprehensive genomic profiling in clinical practice to assess patients with solid tumor cancers.
Molecular Testing Turnaround Times and Treatment Decisions
Variables that impact decisions to initiate therapy for solid tumor cancers versus wait for results of genomic profiling assays.
Comprehensive Genomic Profiling: When to Retest Patients
Oncologists explain scenarios for which they may retest patients previously assessed via genomic profiling.
Comprehensive Genomic Profiling and Informed Decision-Making
How to determine what information from comprehensive genomic profiling assays is relevant vs extraneous when making treatment decisions for patients with solid tumor cancers.
Shifting Over to Comprehensive Genomic Profiling in Oncology
The rationale for migrating away from single, spot testing to comprehensive genomic profiling assays in oncology.
Driver Mutations and Cancer Care
How the identification of certain driver mutations analyzed by genomic assays can be applied into oncology treatment.
Molecular Profiling Complexities and Coverage Decisions
Considerations regarding coverage decisions to support the large amount of information provided by molecular testing assays and the validity of results in terms of clinical decision-making.
